Literature DB >> 12617818

VITO-1, a novel vestigial related protein is predominantly expressed in the skeletal muscle lineage.

Michal Mielcarek1, Stefan Günther, Marcus Krüger, Thomas Braun.   

Abstract

In order to identify novel genes expressed in skeletal muscle we performed a subtractive hybridization for genes expressed in human skeletal muscle but not in other tissues. We identified a novel scalloped interaction domain (SID) containing protein in humans and in the mouse, which we named VITO-1. Highest homology of VITO-1 was found with the Drosophila vestigial and the human TONDU proteins in the SID (54 and 40%, respectively). Using whole-mount hybridzation and Northern blot analysis, we showed that VITO-1 is expressed in the somitic myotome from E8.75 mouse embryos onwards and later on in skeletal muscle but not in the heart. Additional expression domains during development were detected in the pharyngeal pouches and clefts starting at E8.0 as well as in the cranial pharynx and in Rathkes pouch. By Northern blot analysis, we found VITO-1 to be up-regulated in C2C12 myotubes although some expression can be detected in proliferating C2C12 myoblasts. No expression was spotted in other adult mouse tissues. Likewise, expression of human Vito-1 during fetal and adult human development was found exclusively in skeletal muscle preferentially in fast skeletal muscles. These data suggest a role of VITO-1 for the development of skeletal muscles and of pharyngeal clefts/Rathkes' pouch derived structures.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12617818     DOI: 10.1016/s0925-4773(02)00386-6

Source DB:  PubMed          Journal:  Gene Expr Patterns        ISSN: 1567-133X            Impact factor:   1.224


  8 in total

1.  Antagonizing scalloped with a novel vestigial construct reveals an important role for scalloped in Drosophila melanogaster leg, eye and optic lobe development.

Authors:  Ankush Garg; Ajay Srivastava; Monica M Davis; Sandra L O'Keefe; Leola Chow; John B Bell
Journal:  Genetics       Date:  2006-11-16       Impact factor: 4.562

2.  VGLL4 functions as a new tumor suppressor in lung cancer by negatively regulating the YAP-TEAD transcriptional complex.

Authors:  Wenjing Zhang; Yijun Gao; Peixue Li; Zhubing Shi; Tong Guo; Fei Li; Xiangkun Han; Yan Feng; Chao Zheng; Zuoyun Wang; Fuming Li; Haiquan Chen; Zhaocai Zhou; Lei Zhang; Hongbin Ji
Journal:  Cell Res       Date:  2014-01-24       Impact factor: 25.617

3.  VGLL4 inhibits EMT in part through suppressing Wnt/β-catenin signaling pathway in gastric cancer.

Authors:  Hui Li; Ziwei Wang; Wei Zhang; Kun Qian; Gang Liao; Wei Xu; Shouru Zhang
Journal:  Med Oncol       Date:  2015-02-21       Impact factor: 3.064

4.  Downregulation of VGLL4 in the progression of esophageal squamous cell carcinoma.

Authors:  Wei Jiang; Feng Yao; Jing He; Bihong Lv; Wentao Fang; Weidong Zhu; Guangming He; Jianzhong Chen; Jianming He
Journal:  Tumour Biol       Date:  2014-10-30

5.  Vestigial-like-2b (VITO-1b) and Tead-3a (Tef-5a) expression in zebrafish skeletal muscle, brain and notochord.

Authors:  Christopher J Mann; Daniel P S Osborn; Simon M Hughes
Journal:  Gene Expr Patterns       Date:  2007-08-15       Impact factor: 1.224

Review 6.  Genetic control of muscle development: learning from Drosophila.

Authors:  Tariq Maqbool; Krzysztof Jagla
Journal:  J Muscle Res Cell Motil       Date:  2008-03-18       Impact factor: 3.352

7.  mTFkb: a knowledgebase for fundamental annotation of mouse transcription factors.

Authors:  Kun Sun; Huating Wang; Hao Sun
Journal:  Sci Rep       Date:  2017-06-08       Impact factor: 4.379

8.  Vestigial-like 3 is a novel Ets1 interacting partner and regulates trigeminal nerve formation and cranial neural crest migration.

Authors:  Emilie Simon; Nadine Thézé; Sandrine Fédou; Pierre Thiébaud; Corinne Faucheux
Journal:  Biol Open       Date:  2017-10-15       Impact factor: 2.422

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.